日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting LINC00152 activates cAMP/Ca(2+)/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer.

靶向 LINC00152 可激活 cAMP/Ca(2+)/铁死亡轴,并克服 ER+ 乳腺癌的他莫昔芬耐药性

Saatci Ozge, Alam Rashed, Huynh-Dam Kim-Tuyen, Isik Aynur, Uner Meral, Belder Nevin, Ersan Pelin Gulizar, Cetin Metin, Tokat Unal Metin, Gedik Mustafa Emre, Bal Hilal, Sahin Ozlem Sener, Riazalhosseini Yasser, Thieffry Denis, Gautheret Daniel, Ogretmen Besim, Aksoy Sercan, Uner Aysegul, Akyol Aytekin, Sahin Ozgur

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer.

靶向赖氨酰氧化酶(LOX)可克服三阴性乳腺癌的化疗耐药性

Saatci Ozge, Kaymak Aysegul, Raza Umar, Ersan Pelin G, Akbulut Ozge, Banister Carolyn E, Sikirzhytski Vitali, Tokat Unal Metin, Aykut Gamze, Ansari Suhail A, Dogan Hayriye Tatli, Dogan Mehmet, Jandaghi Pouria, Isik Aynur, Gundogdu Fatma, Kosemehmetoglu Kemal, Dizdar Omer, Aksoy Sercan, Akyol Aytekin, Uner Aysegul, Buckhaults Phillip J, Riazalhosseini Yasser, Sahin Ozgur